Internet and vaccine hesitancy in the UK
Investigators: Sofia Amaral-Garcia, Mattia Nardotto, Carol Propper and Tommaso Valletti
Innovation and development of vaccines against COVID-19
Investigators: Philippe Aghion, Mathias Dewatripont, Michel Goldman, Sofia Amaral-Garcia
Market Definition and Competition Policy Enforcement in the Pharmaceutical Industry
Investigators: Georges Siotis, Carmine Ornaghi, Micael Castanheira
Abstract:
We focus on market definition in the pharmaceutical industry, where the introduction of generics in different markets provide a […]
Rogue antibodies could be driving severe COVID-19
Evidence is growing that self-attacking ‘autoantibodies’ could be the key to understanding some of the worst cases of SARS-CoV-2 infection.
Read the full article published by Nature with a contribution […]
Au bout du jour – Interview for Auvio
During the interview given to RTBF Auvio, our co-director, Michel Goldman stressed the importance of the collective intelligence and collaborative research as keys in the fight against the pandemic. […]
L’Echo: La campagne de vaccination est lancée, à quand un relâchement des mesures?
Our co-director, Michel Goldman has given an interview to L’Echo where he discusses COVID-19 vaccines launch in Belgium. Read the full article to find out about the next steps […]
Covid-19 et inégalités
Nous avons le plaisir de vous convier au webinaire organisé par le Collège de France et le Collège Belgique, le 15 janvier 2021 de 9h à 12h. Accès libre […]
Recommendations for a European BARDA
As the EU considers establishing an Agency comparable to the U.S. Biomedical Advanced Research and Development Authority (BARDA), our colleagues outlines a set of recommendations during #A2MDialogues organised by […]
ADVANCE – Educating the next generation of ATMP professionals
ADVANCE is a 30-month EU training project, supported by Erasmus Plus with the objective to develop a 3-stage blended learning programme to support early-career biomedical scientists in developing currently […]